Predicting agranulocytosis in patients treated with clozapine – development and validation of a machine learning algorithm based on 5,550 patients Article Swipe

MAKE IMPACT

Ebenezer Oloyede , Juan Miguel Lopez Alcaraz , Eromona Whiskey , Olubanké Dzahini , Dan W. Joyce , Sukhwinder S. Shergill , Nils Strodthoff , David Taylor , Christian Bachmann · YOU? · · 2025 · Open Access · · DOI: https://doi.org/10.1101/2025.03.07.25323575

Background To prevent clozapine-induced agranulocytosis (CIA), patients’ white blood cell counts are closely monitored, with treatment stopped if the absolute neutrophil count (ANC) drops below 1.5×10 9 /L. While effective, this approach has a high rate of false positives. This study aimed to develop a machine learning (ML) decision-making tool to better predict CIA risk using pattern-based criteria (two consecutive ANCs <0.5×10 9 /L over ≥2 days). Methods Using a ML technique [gradient-boosted decision trees (GDBT)] we analysed clinical data from 5,550 UK patients treated with clozapine: 2,190 controls with no history of neutropenia and 3,360 cases with at least one neutropenic event, including 358 with pattern-based CIA. Using haematological and demographic data from the current and three prior time windows, predictive models estimated the likelihood of CIA across four time-windows: 1 week, 2 weeks, 1 month, and 3 months respectively in advance. Model performance was evaluated using area under the receiver operator characteristic curve (AUROC), sensitivity, and specificity. We developed another model to predict baseline risk of CIA and compared performance with genetic tests. Explainability analyses identified key features influencing predictions. Outcomes GDBT models demonstrated strong predictive performance: 1-week forecasting horizon: AUROC 0.99 [95% confidence interval (CI): 0.99–0.99]; 2 weeks: AUROC 0.97 [95% CI: 0.95–0.99]; 1 month: AUROC 0.91 [95% CI: 0.86–0.94]; 3 months: AUROC 0.90 [95% CI: 0.88–0.92]. The baseline model achieved better performance than current genetic tests, with high specificity and sensitivity at varying thresholds. Key discriminative features for CIA included age and baseline haematological values for longer forecasting horizons (1 and 3 months) and current haematological values and treatment duration for shorter horizons (1 and 2 weeks). Interpretation ML models reliably predict CIA occurrence across short- and long-term horizons, potentially reducing the number of false positives with the current system. Implementation of ML models can reduce unnecessary treatment interruptions and the need for additional blood tests due to suspected agranulocytosis. Funding The study did not receive direct funding. Research in context Evidence before this study The only antipsychotic that is effective for treatmentresistant psychosis is clozapine. Tragically, many patients with treatment-resistant psychosis never receive clozapine treatment or receive it many years after “treatmentresistance”. A prominent reason for this is blood tests that are required to detect potential clozapine-induced agranulocytosis (CIA). Despite monitoring being effective, several patients have had to stop clozapine unnecessarily because of the current haematological criteria for discontinuation. In many of these patients, this has resulted in poor clinical and social outcomes. Additionally, many cases of agranulocytosis are identified late under the existing monitoring protocols. At present, there is no reliable way of predicting clozapine-induced agranulocytosis (CIA). Added value of this study This is the first study to propose that a machine-learning decision tool can reliably predict CIA before it occurs in both the short term and long term. 0.1. Implications of all the available evidence Implementation of machine learning algorithms allow prediction of agranulocytosis so that clozapine can be appropriate stopped before it occurs. The algorithm can also prevent unnecessary stopping of clozapine and additional blood testing that is related to spurious blood results.

Type

preprint

Language

en

Landing Page

https://doi.org/10.1101/2025.03.07.25323575

OA Status

green

Cited By

1

References

26

Related Works

10

OpenAlex ID

https://openalex.org/W4408317132

Raw OpenAlex JSON

OpenAlex ID

https://openalex.org/W4408317132

Canonical identifier for this work in OpenAlex

DOI

https://doi.org/10.1101/2025.03.07.25323575

Digital Object Identifier

Title

Predicting agranulocytosis in patients treated with clozapine – development and validation of a machine learning algorithm based on 5,550 patients

Work title

Type

preprint

OpenAlex work type

Language

en

Primary language

Publication year

2025

Year of publication

Publication date

2025-03-10

Full publication date if available

Authors

Ebenezer Oloyede, Juan Miguel Lopez Alcaraz, Eromona Whiskey, Olubanké Dzahini, Dan W. Joyce, Sukhwinder S. Shergill, Nils Strodthoff, David Taylor, Christian Bachmann

List of authors in order

Landing page

https://doi.org/10.1101/2025.03.07.25323575

Publisher landing page

Open access

Yes

Whether a free full text is available

OA status

green

Open access status per OpenAlex

OA URL

https://doi.org/10.1101/2025.03.07.25323575

Direct OA link when available

Concepts

Clozapine, Computer science, Algorithm, Medicine, Machine learning, Artificial intelligence, Schizophrenia (object-oriented programming), Programming language

Top concepts (fields/topics) attached by OpenAlex

Cited by

1

Total citation count in OpenAlex

Citations by year (recent)

2025: 1

Per-year citation counts (last 5 years)

References (count)

26

Number of works referenced by this work

Related works (count)

10

Other works algorithmically related by OpenAlex

Full payload